FDXF is now down 14% in a month, and the gap between what analysts say the stock is worth and where it actually trades is getting harder to dismiss as a temporary dislocation.
The week's most important development sits on the analyst tape. Stephens & Co. initiated coverage on July 8 with an Overweight rating and a $180 target — the latest entry in a coverage wave that remains decisively bullish in aggregate. Goldman Sachs kicked things off last week at Buy with $186. Jefferies holds the highest target on the Street at $200. Raymond James and Evercore ISI are both Outperform. The bears are a clear minority: Stifel, Truist, and BMO each sit at Hold, with targets ranging from $150 to $160. BMO is worth watching specifically — it lifted its target from $140 to $150 just days before the stock was already trading there, and shares have since fallen to $144.72. The consensus mean across all coverage now runs at roughly $162, implying more than 11% upside from Tuesday's close. A week ago, that implied return was around 7%. The discount to analyst targets is widening, not narrowing.
The borrow market offers little drama to accompany the price weakness. Availability is comfortably loose at roughly 914% — meaning there are about nine shares available to borrow for every one already lent out. That reading is near the tightest level of the very short history the data covers, but remains in loose territory by any standard. Cost to borrow has actually eased, falling 24% on the week to just 0.46%. Short interest has climbed roughly 23% over the past week in share terms, reaching about 3.4 million shares — a genuine acceleration from the near-zero levels that prevailed before late June. Even so, with no free-float percentage calculable and borrow conditions this relaxed, the shorts are building a position rather than pressing a crowded one.
Options positioning paints a more cautious picture. The put/call ratio has run consistently above 1.3 for the past two weeks, touching a 52-week high of 1.43 on June 29. Tuesday's reading of 1.31 remains well elevated relative to the June lows, when the ratio briefly sat below 0.5. That shift from call-heavy to put-heavy coincides almost exactly with the June 25 earnings release, when the stock fell 4.1% on the day and extended losses to 6% over the following five days. Options traders have stayed defensive since. The 52-week low for the PCR is 0.0, reflecting the stock's brief independent trading history, but the directional message is clear: hedging demand has risen sharply and has not relaxed.
The ownership structure is a relevant backdrop. FedEx Corporation remains the dominant holder at just under 20% of shares outstanding — a stake that constrains both the free float and the effective depth of the short book. BlackRock holds 3.1% and State Street 1.6%. Every other institutional name on the register holds under 1%, and total tracked holder count is just fifteen. This is still a thinly traded post-spin with concentrated ownership, which means price moves can outpace what fundamentals alone would justify in either direction.
The next scheduled catalyst is October 9 earnings. Between now and then, the story reduces to whether the analyst consensus — which is broad, recent, and bullishly priced — begins to compress toward where the stock actually trades, or whether the stock finds its footing and closes the gap from the other side.
See the live data behind this article on ORTEX.
Open FDXF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
